phraktion’s Post

View organization page for phraktion, graphic

3,288 followers

We're pleased to have Nur Ferrante Morales join the phraktion community! Nur is a linguistic validation specialist and mentor, an integrative health professional, and therapy poet from Spain. She has a affinity for enhancing patient’s health and wellbeing, as well as supporting patient-centric studies through Clinical Outcome Assessment (COA) science. In her announcement on the phraktion Newsfeed, she says: "I embrace multiculturalism and I wholeheartedly support equity, inclusion and diversity. I work directly with linguistic validation projects as a consultant, and I mentor a comprehensive Linguistic Validation Specialization Course for training medical translators and healthcare professionals in the field. Besides translating, teaching and being of value to patients, I love being an Add Heart® Facilitator (HeartMath Institute) and helping people live connected to their hearts and intuition. I am also a member of Baile de Pingüinos, a multiple sclerosis patients association in Spain dedicated to help MS patients like me to live a satisfying and fulfilling life. I love writing poetry, novels and self-help books, working in Healing Words (my new space dedicated to spirituality, healing and arts), walking in nature, practicing meditation and spending time with my dog and family." Nur is just another example of the great people who are apart of phraktion! Check out Nur's post here: https://lnkd.in/gKkTMHCz #growth #pharma #progress

  • No alternative text description for this image

Welcome aboard !! Welcome to the growing network of Phraktion members Nur Another member joins us with a highly relevant and expert skillset.

Paul Reynolds

Now teaming up to help biotech & pharma companies turn vision into reality. Deep Pharma Launch Experience / NED / Investor & nice Chap

1w

Welcome Nur. Thanks for joining Phraktion. Lots of news share on our network later this month

See more comments

To view or add a comment, sign in

Explore topics